Abstract: The 32 T all-superconducting magnet of the National High Magnetic Field Laboratory (NHMFL) was successfully tested in December 2017 and it is expected to be soon available for users. This ...
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases ...